ARTICLE | Company News
Boehringer settling U.S. Pradaxa litigation
May 29, 2014 1:03 AM UTC
Boehringer Ingelheim GmbH (Ingelheim, Germany) will pay $650 million to settle about 4,000 product liability claims related to Pradaxa dabigatran etexilate. The claims in U.S. state and federal courts...